16th World Conference on Lung Cancer

Schytte, T. (Speaker)

Activity: Talks and presentationsConference presentations

Description

The NARLAL2 phase III trial: Heterogeneous FDG-guided dose escalation of LA-NSCLC A clinical trial by the Danish Lung Cancer Group
Period6. Sep 20159. Sep 2015
Event title16th World Conference on Lung Cancer
Event typeConference
LocationDenver, United States